These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2615711)

  • 1. [Experimental chemotherapy of alveolar hydatid disease. 12. The efficacy of drug forms of mebendazole and nocodazole with high bioavailability].
    Dzhabarova VI; Dobrotvorskiĭ AE; Krotov AI
    Med Parazitol (Mosk); 1989; (5):43-6. PubMed ID: 2615711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental chemotherapy of alveococcosis. 9. The pharmacokinetics and effectiveness of mebendazole when administered by peroral and intramuscular routes to infected mice].
    Dzhabarova VI; Lur'e AA; Krotov AI
    Med Parazitol (Mosk); 1986; (5):63-7. PubMed ID: 3796458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of phospholipids on mebendazole pharmacokinetics in experimental multilocular echinococcosis].
    Lur'e AA; Dzhabarova VI; Krotov AI; Shcherbakov AM
    Med Parazitol (Mosk); 1986; (5):67-71. PubMed ID: 3796459
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental study of the chemotherapy of echinococcosis using intramuscular injections of a mebendazole suspension].
    Krotov AI; Dzhabarova VI; Pereverzeva EV; Lopatin BV; Dobrotvorskiĭ AE
    Med Parazitol (Mosk); 1983; (5):61-3. PubMed ID: 6646057
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental chemotherapy of alveolar hydatid disease. VIII. The comparative effectiveness and toxicity of nocodazole and mebendazole].
    Dzhabarova VI; Krotov AI; Kolosova MO; Drusviatskaia SK; Kovalenko FP
    Med Parazitol (Mosk); 1983; (5):65-8. PubMed ID: 6358825
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental therapy of alveolar hydatid disease. VI. The effect of mebendazole particle size on its toxicity and effectiveness in laboratory animals when administered by various methods].
    Krotov AI; Frol'tsova AE; Dzhabarova VI; Tret'iakov SA; Egorova GG
    Med Parazitol (Mosk); 1978; 47(6):48-50. PubMed ID: 723808
    [No Abstract]   [Full Text] [Related]  

  • 7. [Research progress on the efficacy, metabolism and bioavailability of mebendazole in hydatid disease].
    Liu CS; Zhang HB
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Dec; 27(6):513-9. PubMed ID: 20232637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The enhanced bioavailability of mebendazole in echinococcosis patients when used with Essentiale].
    Shcherbakov AM; Lur'e AA
    Med Parazitol (Mosk); 1993; (1):43-5. PubMed ID: 8336653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the intraperitoneal administration of mebendazole on the immune reactions of mice with experimental hydatid disease].
    Kovrova EA; Frol'tsova AE; Leĭkina ES; Krotov AI
    Med Parazitol (Mosk); 1979; 48(1):78-82. PubMed ID: 431502
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of the possibility of increasing the bioavailability of mebendazole using sunflower oil in echinococcosis].
    Shcherbakov AM; Lur'e AA
    Med Parazitol (Mosk); 1989; (3):46-9. PubMed ID: 2674643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice.
    Ceballos L; Elissondo M; Bruni SS; Denegri G; Alvarez L; Lanusse C
    Parasitol Int; 2009 Dec; 58(4):354-8. PubMed ID: 19628054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of plant oils to increase the bioavailability of mebendazole (in a model of larval unilocular echinococcosis)].
    Lur'e AA; Dzhabarova VI; Krotov AI; Shcherbakov AM
    Med Parazitol (Mosk); 1987; (2):19-22. PubMed ID: 3600502
    [No Abstract]   [Full Text] [Related]  

  • 13. [The experimental chemotherapy of larval alveolar echinococcosis. The search for an optimal regimen of albendazole use].
    Dzhabarova VI; Novik TS
    Med Parazitol (Mosk); 1999; (1):52-5. PubMed ID: 10414050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice.
    Liu CS; Zhang HB; Lei W; Zhang CW; Jiang B; Zheng Q; Yin JH; Han XM
    Parasit Vectors; 2014 Dec; 7():589. PubMed ID: 25491386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental therapy of alveococcosis. 5. Effectiveness of mebendazole: diverse methods of its administration].
    Krotov AI; Tret'iakov SA; Dzhabarova VI; Cherniaeva AI
    Med Parazitol (Mosk); 1977; 46(4):480-4. PubMed ID: 927381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative efficacy of albendazole and mebendazole oily suspensions in albino mice with experimental larval alveococcosis].
    Kovalenko FP; Kukhaleva IV; Shkoliar NA; Legon'kov IuA
    Med Parazitol (Mosk); 2013; (2):17-20. PubMed ID: 24003516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conservative therapy of echinococcal disease: optimization of the mebendazole dosage regimen using a computer].
    Lur'e AA; Shcherbakov AM
    Med Parazitol (Mosk); 1987; (5):13-6. PubMed ID: 3437831
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of dissolution and bioavailability for mebendazole, an agent for human echinococcosis, by preparing solid dispersion with polyethylene glycol.
    Chiba Y; Kohri N; Iseki K; Miyazaki K
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2158-60. PubMed ID: 1797442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis.
    Chaudhary S; Garg T; Rath G; Murthy RR; Goyal AK
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):937-42. PubMed ID: 25783855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental rationale for the optimization of chemotherapy for alveococciasis].
    Chernikova EA; Legon'kov IuA; Kovalenko FP
    Med Parazitol (Mosk); 2005; (1):43-5. PubMed ID: 15801219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.